Adicet Bio Inc (ACET) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACET Annual Balance Sheets →
The table below presents a historical view of Adicet Bio Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent36.25
Other Short-term Investments AS101.35
Cash & Short-term Investments137.00
Prepaid Expense And Other Assets Current2.48
Total Current Assets140.07
Equipment/Property/Plant Net15.18
Other Assets, Noncurrent14.13
Restricted Cash Noncurrent2.87
Operating Lease Right Of Use Asset10.24
Total Assets169.38
Liabilities
Accounts Payable, Current AC2.93
Accrued Liabilities And Other Liabilities12.49
Other Liabilities, Current2.88
Total Current Liabilities18.30
Total Long-term Debt0.00
Other liabilities, Noncurrent11.02
Operating Lease Liability Current2.75
Operating Lease Liability Noncurrent10.16
Total Liabilities29.32
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock775.04
Retained Earnings / Accumulated Deficit-634.94
Other Equity-0.04
Common Stockholder's Equity140.07
Total Stockholder's Equity140.07
Liabilities & Stockholder's Equity169.38
4 historic quarters locked

Sign in to unlock the full Adicet Bio Inc balance sheet history.

About Adicet Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001720580-26-000050

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.